AmpliTech Group Posts Strong Q2 Revenue Growth but Deepens Losses on R&D Push
Event summary
- $8.07M revenue in Q2 2026, up 50.9% sequentially from $5.35M in Q1.
- Gross profit surged 161.2% year-over-year to $2.25M (27.9% margin).
- $3.09M net loss reported, wider than $(1.77)M in prior-year quarter.
- $21.92M raised via Series A Rights offering in July 2026.
- Stock repurchase program authorized for up to $10M over next 24 months.
The big picture
AmpliTech's strong sequential revenue growth reflects accelerating commercialization across its RF/microwave platform, particularly in 5G and defense applications. The company is balancing aggressive R&D investments with operational scaling, a strategy that could position it for larger-volume opportunities but risks near-term profitability. With $21.92M raised via Series A Rights offering and a $10M stock repurchase program authorized, AmpliTech appears focused on maintaining financial flexibility while pursuing growth across its diversified end markets.
What we're watching
- Execution Risk
- Whether AmpliTech can sustain sequential revenue growth while managing widening net losses from R&D investments.
- Market Diversification
- How the company's exposure to four principal markets will drive future growth and operational leverage.
- Capital Allocation
- The pace at which AmpliTech deploys its $10M stock repurchase program against ongoing R&D needs.
Related topics
